The role of integrins in the modulation of neurotransmitter release from motor nerve terminals by stretch and hypertonicity. 2003

Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
Department of Physiology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1751, USA. adg@ucla.edu

Integrins are found at most or all synapses and play a variety of roles. At frog neuromuscular junctions, mechanical tension on integrins due to muscle stretch or hypertonicity causes a powerful modulation of release efficacy. Understanding the mechanism(s) of integrin-mediated modulation will likely further our understanding of mechanisms of neurotransmitter release. The modulation of evoked release with stretch occurs with no detectable delay, does not adapt, and bypasses the Ca(2+) triggering step in vesicle fusion. It depends primarily on integrin bonds to native ligands and requires that one or more proteins in the link between integrins and vesicle fusion be dephosphorylated. Hypertonicity, studied in both frog and Drosophila terminals, causes a larger but slower phasic-tonic change in spontaneous release, which is also Ca(2+)-independent and mostly dependent on integrins, but not dependent on the phosphorylation state of molecules in its pathway of action. In Drosophila, the integrin-dependent component involves the cAMP/PKA pathway, and is absent in mutants lacking PKA. Both stretch and hypertonicity responses in frog terminals are enhanced by agents that elevate PKA levels, suggesting that, in frogs, the cAMP/PKA cascade primarily determines the size of the pool of vesicles available for release by the integrin-mediated mechanism and is not a direct intermediary in the modulation. Evoked release is affected little or even inhibited by hypertonicity. In Drosophila, the inhibition can be explained by a decrease in Ca(2+) influx. The effect of hypertonicity on evoked release in frogs may similarly be a balance between mechanisms that enhance spontaneous release and those that suppress I (Ca).

UI MeSH Term Description Entries
D009045 Motor Endplate The specialized postsynaptic region of a muscle cell. The motor endplate is immediately across the synaptic cleft from the presynaptic axon terminal. Among its anatomical specializations are junctional folds which harbor a high density of cholinergic receptors. Motor End-Plate,End-Plate, Motor,End-Plates, Motor,Endplate, Motor,Endplates, Motor,Motor End Plate,Motor End-Plates,Motor Endplates
D009046 Motor Neurons Neurons which activate MUSCLE CELLS. Neurons, Motor,Alpha Motorneurons,Motoneurons,Motor Neurons, Alpha,Neurons, Alpha Motor,Alpha Motor Neuron,Alpha Motor Neurons,Alpha Motorneuron,Motoneuron,Motor Neuron,Motor Neuron, Alpha,Motorneuron, Alpha,Motorneurons, Alpha,Neuron, Alpha Motor,Neuron, Motor
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009470 Muscle Spindles Skeletal muscle structures that function as the MECHANORECEPTORS responsible for the stretch or myotactic reflex (REFLEX, STRETCH). They are composed of a bundle of encapsulated SKELETAL MUSCLE FIBERS, i.e., the intrafusal fibers (nuclear bag 1 fibers, nuclear bag 2 fibers, and nuclear chain fibers) innervated by SENSORY NEURONS. Muscle Stretch Receptors,Neuromuscular Spindles,Receptors, Stretch, Muscle,Stretch Receptors, Muscle,Muscle Spindle,Muscle Stretch Receptor,Neuromuscular Spindle,Receptor, Muscle Stretch,Receptors, Muscle Stretch,Spindle, Muscle,Spindle, Neuromuscular,Spindles, Muscle,Spindles, Neuromuscular,Stretch Receptor, Muscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016023 Integrins A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation. Integrin
D017729 Presynaptic Terminals The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included. Axon Terminals,Nerve Endings, Presynaptic,Synaptic Boutons,Synaptic Terminals,Axon Terminal,Bouton, Synaptic,Boutons, Synaptic,Ending, Presynaptic Nerve,Endings, Presynaptic Nerve,Nerve Ending, Presynaptic,Presynaptic Nerve Ending,Presynaptic Nerve Endings,Presynaptic Terminal,Synaptic Bouton,Synaptic Terminal,Terminal, Axon,Terminal, Presynaptic,Terminal, Synaptic,Terminals, Axon,Terminals, Presynaptic,Terminals, Synaptic
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
January 2011, Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections,
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
December 2004, The European journal of neuroscience,
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
June 1975, The Journal of physiology,
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
January 1994, Advances in second messenger and phosphoprotein research,
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
April 2010, Synapse (New York, N.Y.),
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
April 1974, Proceedings of the National Academy of Sciences of the United States of America,
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
June 1972, Nature,
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
May 1993, Biochemical Society transactions,
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
January 1967, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
Alan D Grinnell, and Bo-Ming Chen, and Amir Kashani, and Jennifer Lin, and Kazuhiro Suzuki, and Yoshiaki Kidokoro
December 1972, The Journal of physiology,
Copied contents to your clipboard!